| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 10,000 | $29.58 | $295,839.00 | View Details Filing |
| Feb 12, 2026 | Enliven Therapeutics, Inc. (ELVN) | A | 150,000 | $0.00 | $0.00 | View Details Filing |
| Feb 12, 2026 | Enliven Therapeutics, Inc. (ELVN) | A | 25,000 | $0.00 | $0.00 | View Details Filing |
| Dec 22, 2025 | Enliven Therapeutics, Inc. (ELVN) | M | 13,000 | $0.00 | $0.00 | View Details Filing |
| Dec 22, 2025 | Enliven Therapeutics, Inc. (ELVN) | M | 13,000 | $2.48 | $32,240.00 | View Details Filing |